Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07265921
What this trial is testing

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 232
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Testing effectiveness (Phase 2)Looking for participantsNCT07105215
What this trial is testing

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Who this might be right for
Solid Tumors
RemeGen Co., Ltd. 312
Early research (Phase 1)Study completedNCT04257110
What this trial is testing

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

Who this might be right for
Locally Advanced/Metastatic HER2 Positive Solid Tumors
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 117
Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Early research (Phase 1)Study completedNCT03468426
What this trial is testing

Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

Who this might be right for
Non-squamous, Non-Small-Cell Lung CancerNeoplasms
Boehringer Ingelheim 252
Testing effectiveness (Phase 2)Ended earlyNCT05326035
What this trial is testing

WJ05129 in Advanced Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Suzhou Junjing BioSciences Co., Ltd. 26
Early research (Phase 1)Study completedNCT01409343
What this trial is testing

TrasGEX™: Phase 1 Study in Cancer Patients

Who this might be right for
Solid Tumors
Glycotope GmbH 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)UnknownNCT05028478
What this trial is testing

CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorHematologic Malignancies
Curon Biopharmaceutical (Australia) Co Pty Ltd 164
Testing effectiveness (Phase 2)Looking for participantsNCT07193511
What this trial is testing

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+1 more
Avenzo Therapeutics, Inc. 355
Early research (Phase 1)Looking for participantsNCT05719558
What this trial is testing

ASP1002 in Adults for Treatment of Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 798
Early research (Phase 1)Not Yet RecruitingNCT07583316
What this trial is testing

First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more
Corregene Biotechnology Co., Ltd 192
Testing effectiveness (Phase 2)WithdrawnNCT03427320
What this trial is testing

Imaging of Advanced Tumours Using [131]I-IAZA

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
University of Alberta
Testing effectiveness (Phase 2)Looking for participantsNCT07359820
What this trial is testing

Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

Who this might be right for
FGFR2 Gene Fusion/RearrangementOther Solid Tumors, Adult
Elevar Therapeutics 30
Early research (Phase 1)UnknownNCT06175780
What this trial is testing

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasms by Histologic Type
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. 189
Early research (Phase 1)Active Not RecruitingNCT07131189
What this trial is testing

FL115 Monotherapy in Unresectable or Metastatic Solid Tumors

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Suzhou Forlong Biotechnology Co., Ltd 30
Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Early research (Phase 1)Ended earlyNCT04842630
What this trial is testing

Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jiangsu HengRui Medicine Co., Ltd. 11
Early research (Phase 1)Active Not RecruitingNCT05378425
What this trial is testing

NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+2 more
Nectin Therapeutics Ltd 90
Next Page